-The Hindu The RCEP is a regional trade agreement being negotiated between the 10 ASEAN countries currently in Auckland. Humanitarian aid organisation Médecins Sans Frontières (MSF) has warned India that the country will not remain ‘pharmacy of the developing world’ if the proposals in the Regional Comprehensive Economic Partnership agreement (RCEP) are adopted. The RCEP is a regional trade agreement being negotiated between the 10 ASEAN countries currently in Auckland. MSF Access Campaign...
More »SEARCH RESULT
Total Matching Records found : 188
Intellectual Property Rights policy may hinder drug access -Vidya Krishnan and Puja Mehra
-The Hindu The policy fails to acknowledge that IP is a market-driven model’ India’s National Intellectual Property Rights (IPR) policy, unveiled on Friday, could pose a “serious” hurdle to allowing access to affordable drugs and the South Asian nation missed a chance to put in place a progressive policy, according to experts. The policy left the country’s patent laws intact and specifically did not open up Section 3(d) of the Patents Act, which...
More »Cash transfers: Lost in transactions -Aarushi Kalra
-The Tribune The Centre for Equity Studies, Delhi, conducted a survey to gauge the impact of the switch to cash transfers on the consumption patterns of the poor in Chandigarh. The preference for kind vis-a-vis cash transfers was recorded. Importantly, public opinion found no place in the decision- making process. Feroza Begum had to make a choice between food security and her children's education. Allow me to rephrase it: Feroza Begum had...
More »Why India needs to show some spine -Leena Menghaney
-The Hindu In the area of intellectual property, public health and access to medicines, the Narendra Modi government should consider its independence to be of the utmost importance. Strong government leadership as well as flexible intellectual property systems are needed in order to effectively combat drug-resistant tuberculosis (DR-TB) and HIV and also antimicrobial resistance and non-communicable diseases. This is true not only for India but also countries which rely on affordable generic...
More »‘Policy on rare diseases will make treatment affordable, inclusive’ -Cinthya Anand
-The Hindu Patients face discrimination because public health systems and schools are not equipped to deal with the problem Bengaluru: “The cost of my daughter's treatment is around Rs. 1 crore per annum. If it were not for the aid of a United States-based foundation, I would not be able to help her,” said Prasanna B. Shirol, founder-director, Organisation for Rare Diseases India. His teenage daughter suffers from Pompe Disease, a rare...
More »
